Lingual protrusion dystonia: Frequency, etiology and botulinum toxin therapy

Parkinsonism and Related Disorders

Volumn 16, Issue 7, 2010, Pages 438-441

  Esper, Christine D ^a   Freeman, Alan ^a   Factor, Stewart A ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Botulinum toxin; Cranial dystonia; Lingual protrusion dystonia; Symptomatic dystonia; Tardive dystonia

Indexed keywords

AMANTADINE; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; BENZATROPINE; BENZODIAZEPINE DERIVATIVE; BOTULINUM TOXIN A; CARBIDOPA PLUS LEVODOPA; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONAZEPAM; DIPHENHYDRAMINE; LORAZEPAM; NEUROLEPTIC AGENT; TRIHEXYPHENIDYL; MUSCLE RELAXANT AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN DYSFUNCTION; CHILD; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DEMYELINATING DISEASE; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG WITHDRAWAL; DYSARTHRIA; DYSPHAGIA; FEMALE; GENERALIZED DYSTONIA; HUMAN; LINGUAL PROTRUSION DYSTONIA; MALE; MEDICAL RECORD REVIEW; MULTIFACTORIAL GENETIC DISORDER; OROMANDIBULAR DYSTONIA; PRIORITY JOURNAL; RARE DISEASE; RECURRENT DISEASE; RISK REDUCTION; SCHOOL CHILD; SKIN BRUISING; STOMACH TUBE; TONGUE DISEASE; XEROSTOMIA; DRUG EFFECTS; DYSTONIA; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; TONGUE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED, 80 AND OVER; BOTULINUM TOXIN TYPE A; CHILD; DYSTONIA; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; RETROSPECTIVE STUDIES; TONGUE; YOUNG ADULT; BOTULINUM TOXINS, TYPE A;

EID: 77954953999     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2010.04.007     Document Type: Article

References (30)

1. Baik J.S., Park J.H., Kim J.Y. Primary lingual dystonia induced by speaking. Mov Disord 2004, 19:1251-1252.
2. Ishii K., Tamaoka A., Shoji S. A case of primary focal lingual dystonia induced by speaking. Eur J Neurol 2001, 8:507.
3. Tan E.K., Chan L.L. Sensory tricks and treatment in primary lingual dystonia. Mov Disord 2005, 20:388.
4. Schneider S.A., Aggarwal A., Bhatt M., Dupont E., Tisch S., Limousin P., et al. Severe tongue protrusion dystonia: clinical syndromes and possible treatment. Neurology 2006, 67:940-943.
5. Marsden C.D. Blepharospasm-oromandibular dystonia syndrome (Brueghel's syndrome). A variant of adult-onset torsion dystonia?. J Neurol Neurosurg Psychiatry 1976, 39:1204-1209.
6. Tan E.K., Jankovic J. Tardive and idiopathic oromandibular dystonia: a clinical comparison. J Neurol Neurosurg Psychiatry 2000, 68:186-190.
7. Hennings J.M., Krause E., Botzel K., Wetter T.C. Successful treatment of tardive lingual dystonia with botulinum toxin: case report and review of the literature. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:1167-1171.
8. Keane J.R. Galloping tongue: post-traumatic, episodic, rhythmic movements. Neurology 1984, 34:251-252.
9. Ondo W. Lingual dystonia following electrical injury. Mov Disord 1997, 12:253.
10. Dabrowski E., Smathers S.A., Ralstrom C.S., Nigro M.A., Leleszi J.P. Botulinum toxin as a novel treatment for self-mutilation in Lesch-Nyhan syndrome. Dev Med Child Neurol 2005, 47:636-639.
11. Gollomp S.M., Fahn S. Transient dystonia as a complication of varicella. J Neurol Neurosurg Psychiatry 1987, 50:1228-1229.
12. Greene P., Shale H., Fahn S. Analysis of open-label trials in torsion dystonia using high dosages of anticholinergics and other drugs. Mov Disord 1988, 3:46-60.
13. Jankovic J., Beach J. Long-term effects of tetrabenazine in hyperkinetic movement disorders. Neurology 1997, 48:358-362.
14. Klawans H.L., Tanner C.M. Cholinergic pharmacology of blepharospasm with oromandibular dystonia (Meige's syndrome). Adv Neurol 1988, 49:443-450.
15. Soares K.V., McGrath J.J. The treatment of tardive dyskinesia - a systematic review and meta-analysis. Schizophr Res 1999, 39:1-16.
16. Kenney C., Hunter C., Jankovic J. Long-term tolerability of tetrabenazine in the treatment of hyperkinetic movement disorders. Mov Disord 2007, 22:193-197.
17. Ondo W.G., Hanna P.A., Jankovic J. Tetrabenazine treatment for tardive dyskinesia: assessment by randomized videotape protocol. Am J Psychiatry 1999, 156:1279-1281.
18. van Harten P.N., Kahn R.S. Tardive dystonia. Schizophr Bull 1999, 25:741-748.
19. Charles P.D., Davis T.L., Shannon K.M., Hook M.A., Warner J.S. Tongue protrusion dystonia: treatment with botulinum toxin. South Med J 1997, 90:522-525.
20. Kasravi N., Jog M.S. Botulinum toxin in the treatment of lingual movement disorders. Mov Disord 2009, 24:2199-2202.
21. Blitzer A., Brin M.F., Fahn S. Botulinum toxin injections for lingual dystonia. Laryngoscope 1991, 101:799.
22. Hallett M., Benecke R., Blitzer A., Comella C.L. Treatment of focal dystonias with botulinum neurotoxin. Toxicon 2009, 54:628-633.
23. Factor S.A., Barron K.D. Mosaic pattern of gliosis in the neostriatum of a North American man with craniocervical dystonia and parkinsonism. Mov Disord 1997, 12:783-789.
24. Lungu C., Aia P.G., Shih L.C., Esper C.D., Factor S.A., Tarsy D. Tardive dyskinesia due to aripiprazole: report of 2 cases. J Clin Psychopharmacol 2009, 29:185-186.
25. Schrag A., Bhatia K.P., Quinn N.P., Marsden C.D. Atypical and typical cranial dystonia following dental procedures. Mov Disord 1999, 14:492-496.
26. Fahn S., Marsden C.D., Calne D.B. Classification and investigation of dystonia. Movement disorders 2 1987, 332-358. Butterworths, London. C.D. Marsden, S. Fahn (Eds.).
27. Marsden C.D. The focal dystonias. Clin Neuropharmacol 1986, 9(Suppl. 2):S49-S60.
28. Meige H. Les convulsion de la face, una forme clinique de convulsion faciale bilateral et mediane. Rev Neurol 1910, 21:437-443.
29. Tolosa E., Marti M.J. Blepharospasm-oromandibular dystonia syndrome (Meige's syndrome): clinical aspects. Adv Neurol 1988, 49:73-84.
30. Tolosa E.S., Klawans H.L. Meiges disease: a clinical form of facial convulsion, bilateral and medial. Arch Neurol 1979, 36:635-637.